Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
PaperCitations, authors & open-access status
Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,197 citations, 2015 year and bronze oa status.
1,197
Citations
2015
Year
bronze
OA Status